Table A2.
KNUH clinical data.
| Clinical Data | Total (n = 181) | Malignancy (n = 145) | Benign (n = 36) |
|---|---|---|---|
| Age, yr (min-max) | 67.2 (31–88) | 69.0 (46–88) | 60.3 (31–85) |
| Sex, male (%) | 116 (64.1) | 90 (62.1) | 26 (72.2) |
| Pathologic diagnosis, n (%) | |||
| NSCLC | 118 (65.2) | 118 (81.4) | 0 |
| Adenocarcinoma | 87 (48.1) | 87 (73.3) | |
| Squamous cell carcinoma | 25 (13.8) | 25 (21.1) | |
| Large cell endocrine carcinoma | 3 (1.7) | 3 (2.5) | |
| NSCLC | 3 (1.7) | 3 (2.5) | |
| SCLC | 5 (2.8) | 5 (3.4) | 0 |
| Other type of lung malignancy | 6 (3.3) | 6 (4.1) | 0 |
| Malignancy other than lung | 16 (8.8) | 16 (11.0) | 0 |
| Negative for malignancy | 33 (18.2) | 0 | 33 (91.7) |
| NA | 3 (1.7) | 0 | 3 (8.3) |
| Methods for pathologic diagnosis | |||
| PCNA | 92 (50.8) | 70 (48.3) | 22 (61.1) |
| Surgical operation | 86 (47.5) | 75 (51.7) | 11 (30.6) |
| Contrast-enhanced Chest CT (≥2 years) | |||
| No growth | 3 (1.7) | 3 (8.3) | |
| Disappearance | 0 | 0 |